...Done!
Skip to main content
🔍 See what insiders are buying — free 7-day trial, no credit card required. Get started →
DVA NYSE 🇺🇸 US
DaVita Inc.
Healthcare
Watch
Price Zone: Hold / Watch
🔒 Full AI Analysis — Pro
40Score
DipBuster Score™
$193.31 +$9.38 (+5.1%) Live price · Source: Yahoo
52-Week Position
$101.00 63% of range $247.49
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$247.49
52W Low$101.00
DipBuster Brief Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (63% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position63% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share—
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒 FCF, margins & balance sheet data are hidden — create a free account to see them.
Charts

Recent director dealings and insider transactions at DaVita Inc. (DVA), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.

Date Insider Type Shares
2026-09-22 Maughan David Paul SELL 7,501
2026-08-15 Pullin Dennis W BUY 278
2026-08-15 Moore Gregory J. BUY 278
2026-08-15 Hollar Jason M. BUY 278
2026-08-15 Arway Pamela M BUY 278
2026-08-15 Schechter Adam H BUY 278
2026-08-15 Schoppert Wendy Lee BUY 278
2026-08-15 Yale Phyllis R BUY 278
2026-08-15 Desoer Barbara J BUY 278
2026-07-31 Berkshire Hathaway Inc SELL 182,980

Valuation

P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$247.49
52W Low$101.00

52-Week Range

$101.00Now$247.49
63% through annual range
From 52W High−21.9%
From 52W Low+91.4%
📖 Plain English Summary
DaVita Inc. is at 63% of its 52-week range.

🏦 Analyst Price Target

Loading…

🎯 Analyst Revenue & EPS Estimates

Loading estimates…

🔄 Peer Comparison

Loading peers…
Loading dividend data…
Latest news for DVA 🟢 Bullish ⬜ Neutral 🔴 Bearish
🤖
DipBuster AI Analysis — DVA
Heuristic · balance sheet, insider filings, price data, academic research

DaVita Inc. — DipBuster Score 40/100

Graham value assessment, NCAV analysis, price zones...

Insider signals, cluster detection, risk factors...

🔒
Full AI Analysis — Pro
Price zones, Graham analysis, insider signals
Upgrade →

Track DaVita Inc. free

Add DVA to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.

Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Open Free Account →
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E 0/30
Dip Position 15/25
Momentum & Volume 20/25
Quality & Size 5/10
Insider Activity 0/10
🎯 Dip Buyer Signal
3 /100 · NEUTRAL
dip depth 3/25
oversold rsi 0/25
mean reversion 0/15
insider zone 0/25
capitulation 0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 40/100
📈 Strong recent momentum — price and volume trending in the right direction.

More Healthcare stocks

UNH UnitedHealth GroupJNJ Johnson & JohnsonABT Abbott LaboratoriesTMO Thermo Fisher ScientificDHR Danaher Corp.MDT Medtronic plcSYK Stryker Corp.BSX Boston ScientificAll Healthcare stocks →